ETDRS: Visual Performance of Pseudophakic Patient With Different Intraocular Lenses

Sponsor
Hospital Oftalmologico de Brasilia (Other)
Overall Status
Unknown status
CT.gov ID
NCT01763411
Collaborator
University of Sao Paulo (Other)
80
1
107
0.7

Study Details

Study Description

Brief Summary

This retrospective study comprised patients with cataract, corneal astigmatism, and motivation for spectacle independence. In all cases, a multifocal and monofocal Intraocular Lens was been implanted in the capsular bag. Three months postoperatively, distance, intermediate, and near visual acuities; spherical equivalent; residual refractive astigmatism; defocus curve; and contrast sensitivity was evaluated. A patient-satisfaction and visual phenomena questionnaire was also been administered.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Postoperative evaluation was performed at 3 months. The uncorrected and corrected distance visual acuity were assessed using the 100% contrast Early Treatment Diabetic Retinopathy Study chart, uncorrected intermediate visual acuity at 70 cm, and uncorrected near visual acuity at 40 cm; a binocular defocus curve was constructed using the ETDRS chart at 4 m and adding to the patient's manifest refraction +2.50 to -5.00 D sphere in 0.50 increments. The cylinder axis of the Intraocular lens (IOL) was measured at the slitlamp using the beam protractor after full mydriasis. The mean of the absolute values of degrees the intraocular lens was off axis was determined.

    Contrast sensitivity was measured using the CSV-1000 HGT instrument (VectorVision, Inc.), which presents a translucent chart divided into 4 cycles with spatial frequencies of 3, 6, 12 and 18 cycles per degree. The background illumination of the translucent chart does not depend on room lighting. All measurements were obtained under mesopic (5 cd/m2) and photopic (85 cd/m2) conditions. The examinations were performed unilaterally at a distance of 2.5 m with Best-corrected visual acuity (BCVA) and an undilated pupil. All measurements were performed under the same conditions.

    Patient satisfaction and quality of life were assessed by a simple questionnaire. Patients were interviewed 3 months postoperative. Patients were asked about visual disturbances, visual lifestyle activities, spectacle use, and satisfaction with the procedure.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    80 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Visual Performance of Pseudophakic Patient With Different Intraocular Lenses
    Study Start Date :
    Jan 1, 2008
    Anticipated Primary Completion Date :
    Feb 1, 2016
    Anticipated Study Completion Date :
    Dec 1, 2016

    Arms and Interventions

    Arm Intervention/Treatment
    Multifocal Spheric Intraocular Lens (Restor SN60D3 IOL)

    No Intervention: Multifocal Spheric IOL implantation

    Monofocal Spheric Intraocular Lens (AcrySof SN60AT IOL)

    No Intervention: Monofocal Spheric IOL implantation

    Multifocal Aspheric Intraocular Lens (Tecnis ZMA00 IOL)

    No intervention Multifocal IOL implantation

    Monofocal Aspheric Intraocular Lens (AcrySof SN60WF IOL)

    No Intervention: Monofocal IOL implantation

    Multifocal Aspheric Intraocular Lens (Tecnis ZMB00 IOL)

    No intervention Multifocal IOL implantation

    Multifocal Spheric Intraocular Lens (Restor SN6AD1 IOL)

    No intervention Multifocal IOL implantation

    Outcome Measures

    Primary Outcome Measures

    1. Visual Performance in Pseudophakic Patients With Different Intraocular Lens [6 months postoperative]

      Postoperative evaluation was been performed at 6 months. The uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) was assessed using the 100% contrast ETDRS chart; a binocular defocus curve was constructed using the ETDRS chart at 4 m.

    Secondary Outcome Measures

    1. Contrast sensitivity [6 months]

      Contrast sensitivity was measured using the CSV-1000 HGT instrument (VectorVision, Inc.), which presents a translucent chart divided into 4 cycles with spatial frequencies of 3, 6, 12 and 18 cycles per degree (cpd). The background illumination of the translucent chart does not depend on room lighting. All measurements was obtained under mesopic (5 cd/m2) and photopic (85 cd/m2) conditions. The examinations was performed unilaterally at a distance of 2.5 m with BCVA and an undilated pupil. All measurements was performed under the same conditions.

    2. Patient satisfaction [6 months]

      Patient satisfaction and quality of life was assessed by a simple questionnaire. Patients was interviewed 6 months postoperative. Patients was asked about visual disturbances, visual lifestyle activities, spectacle use, and satisfaction with the procedure.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    55 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Cataract Any race Either gender Diagnosis of cataracts both eyes Pre-existing physical conditions that could skew visual results, such as Diabetes, Retinal detachment, Macular degeneration, or Cancer Subjects must have > 1.00 diopter of astigmatism

    Exclusion Criteria:

    Central endothelial cell count less than 2000 cells/mm2 glaucoma or intraocular pressure greater than 21 mmHg amblyopia Retinal abnormalities Diabetes mellitus steroid or immunosuppressive treatment Connective tissue diseases

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Sao Paulo Sao Paulo Brazil 05403010

    Sponsors and Collaborators

    • Hospital Oftalmologico de Brasilia
    • University of Sao Paulo

    Investigators

    • Principal Investigator: Wilson T Hida, MD, University of Sao Paulo, Brazil
    • Study Chair: Newton J Kara-Junior, MD PhD, University of Sao Paulo, Brazil
    • Principal Investigator: Celso T Nakano, MD, University of Sao Paulo, Brazil
    • Study Director: Patrick Tzelikis, MD PhD, Hospital Oftalmologico de Brasilia
    • Principal Investigator: Mario Augusto D Chaves, MD, Hospital Oftalmologico de Brasilia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Wilson Takashi Hida, MD PhD, Hospital Oftalmologico de Brasilia
    ClinicalTrials.gov Identifier:
    NCT01763411
    Other Study ID Numbers:
    • HOB-12/12
    • HOB03012013
    First Posted:
    Jan 8, 2013
    Last Update Posted:
    Feb 23, 2016
    Last Verified:
    Feb 1, 2016
    Keywords provided by Wilson Takashi Hida, MD PhD, Hospital Oftalmologico de Brasilia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 23, 2016